Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2000
10/31/2000US6139841 Activating immune response in an individual for treatment or prevention of cancer
10/31/2000US6139835 Homologous recombination for allogeneic donor cells
10/31/2000US6139832 Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
10/31/2000US6139817 Identifying varying levels of genes essential to infectivity and growth of a pathogen through use of an expression vector system which uses a promoter that is ?off? in vitro, and turns ?on? selectively during a phase of the infection
10/31/2000CA2197684C Human-murine chimeric antibodies against respiratory syncytial virus
10/31/2000CA2175451C Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto
10/31/2000CA2142879C Method of treating cell damage or depletion
10/31/2000CA2025605C Method of purifying human serum albumin
10/31/2000CA2009403C A packaging defective hiv provirus, cell lines, and uses thereof
10/31/2000CA1341131C Human nerve growth factor
10/31/2000CA1341130C Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology
10/28/2000CA2300229A1 Physiologically-active health foods
10/26/2000WO2000063692A1 Secreted proteins and polynucleotides encoding them
10/26/2000WO2000063691A2 Method for detecting mismatches or mutations in nucleic acid
10/26/2000WO2000063438A2 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000WO2000063435A2 Method of identifying toxic agents using differential gene expression
10/26/2000WO2000063434A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA
10/26/2000WO2000063427A2 Compound screening method
10/26/2000WO2000063426A2 Compound screening methods
10/26/2000WO2000063417A2 Proteins that regulate systemic acquired resistance in plants
10/26/2000WO2000063415A1 Dna encoding the human vanilloid receptor vr1
10/26/2000WO2000063410A1 Methods and compositions for transforming cells using site-specific recombination
10/26/2000WO2000063406A2 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules
10/26/2000WO2000063405A1 Vectors containing a gene coding for cd40 and/or cd40l under the control of a cytokine-inducible promoter, methods for their production and uses thereof
10/26/2000WO2000063404A1 New expression systems using introns
10/26/2000WO2000063403A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
10/26/2000WO2000063395A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000WO2000063387A1 The full gene sequence of the donkey leukocyte vaccine strain of the equine infectious anemia virus and their application
10/26/2000WO2000063386A2 Prevention, diagnosis and treatment of lyme disease
10/26/2000WO2000063384A1 Streptokinase fragments and their use for inhibiting cell death
10/26/2000WO2000063383A1 IgA BINDING POLYPEPTIDE
10/26/2000WO2000063382A1 Genes and expression products from hematopoietic cells
10/26/2000WO2000063381A1 Mammalian protein with putative function in signal transduction
10/26/2000WO2000063380A1 Vascular endothelial cell growth factor variants and uses thereof
10/26/2000WO2000063379A2 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000WO2000063378A2 Zalpha13: a human secreted protein
10/26/2000WO2000063377A1 Adipocyte complement related protein homolog zacrp3
10/26/2000WO2000063376A1 Adipocyte complement related protein homolog zacrp2
10/26/2000WO2000063375A1 Dna encoding a kinesin-like protein (hklp) comprising biallelic markers
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063373A1 A method of altering the properties of a membrane-associated protein by substitution of the transmembrane domain
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063371A1 Protease activated receptor 2 variants
10/26/2000WO2000063370A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000WO2000063368A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000WO2000063367A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
10/26/2000WO2000063363A1 Peptide from antigen muc-1 for triggering an immune response to tumor cells
10/26/2000WO2000063360A1 Combinatorial method for producing nucleic acids
10/26/2000WO2000063357A2 Methods and compositions for modulating ciliary neurotrophic factor activity
10/26/2000WO2000063352A2 Human homologues of fused gene
10/26/2000WO2000063349A1 Human hac3
10/26/2000WO2000063347A1 Methods for enhancing plant defense
10/26/2000WO2000063346A1 A bacillus protein production cell
10/26/2000WO2000063253A1 Agp-1 fusion protein compositions and methods
10/26/2000WO2000063249A1 Polypeptides derived from endostatin exhibiting antiangiogenic activity
10/26/2000WO2000063248A2 Highly purified gonadotropin compositions and process for preparing them
10/26/2000WO2000063247A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000WO2000063246A2 Compounds and methods for modulating beta-catenin mediated gene expression
10/26/2000WO2000063245A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
10/26/2000WO2000063244A1 Parasite antigens
10/26/2000WO2000063243A1 Derivatives of the b or z domain from staphylococcal protein a (spa) interacting with at least one domain of human factor viii
10/26/2000WO2000063242A1 Chimeric lyssavirus nucleic acids and polypeptides
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063236A2 Adhesion modulatory peptides and methods for use
10/26/2000WO2000063231A1 Lymphocyte platelet binding factor as a serum marker for cancer
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063226A1 Interleukin-1 homologue, il-1h4
10/26/2000WO2000063221A2 Galectin 11
10/26/2000WO2000062795A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/26/2000WO2000062791A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000WO2000062789A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/26/2000WO2000062620A2 Transformed cells useful for the control of pests
10/26/2000WO2000062615A1 Neuropeptides and their use for pest control
10/26/2000WO2000049134A8 Secreted proteins and polynucleotides encoding them
10/26/2000WO2000040727A3 Recombinant growth factor with the biological activity of a g-csf (granulocyte colony stimulating factor)
10/26/2000WO2000040719A3 Tissue repair protein involved in orofacial clefting and uses thereof
10/26/2000WO2000037646A3 Group b streptococcus proteins, and their use
10/26/2000WO2000037099A3 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
10/26/2000WO2000036143A3 Selecting animals for parentally imprinted traits
10/26/2000WO2000036108A3 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides
10/26/2000WO2000035481A3 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
10/26/2000WO2000035477A3 Multi-component vaccine comprising at least two antigens from haemophilus influenzae
10/26/2000WO2000034476A3 Nucleic acid molecules of shrimp
10/26/2000WO2000034465A3 HEAT SHOCK GENES AND PROTEINS FROM NEISSERIA MENINGITIDIS, CANDIDA GLABRATA AND $i(ASPERGILLUS FUMIGATUS)
10/26/2000WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1')
10/26/2000WO2000032751A3 Mammalian non-neuronal cells that are modified to store and release a neurotransmitter
10/26/2000WO2000027873A9 Interleukin-2 binding protein from arthropods
10/26/2000WO2000026391A3 Trans-species transfer of apoptotic genes and transgenic plants developed thereby
10/26/2000WO2000026385A9 Nucleic acid constructs for genetic immunization
10/26/2000WO2000024770A9 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
10/26/2000WO2000018922A3 Human carbohydrate-associated proteins
10/26/2000WO2000018906A3 Shuffling of codon altered genes
10/26/2000WO2000018905A9 Method of producing permuteins by scanning permutagenesis
10/26/2000WO2000018795A3 Compositions and methods for wt1 specific immunotherapy
10/26/2000WO2000011172A9 Antithrombin nucleotides and proteins from horn fly
10/26/2000WO2000011032A9 Method for producing biostatin (tt-232 triacetate) and analogs thereof
10/26/2000WO2000006206A9 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/26/2000DE19945798C1 Recovery of bacteriorhodopsin, useful e.g. as light-energy converter for data storage, by growing halobacteria in medium containing nitrogen source other than peptone
10/26/2000DE19920044A1 Expression bakterieller Kaliumkanäle in eukaryontischen Wirtszellen und deren Verwendung zur Identifizierung von Antibiotika Expression of bacterial potassium channels in eukaryotic host cells and their use for identifying antibiotics
10/26/2000DE19918682A1 New recombinant DNA encoding an allergen produced by grasses of the Poaceae family, useful for diagnosis of pollen allergy and for treatment by desensitization
1 ... 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 ... 2916